Skip to main content
Clinical Trials/JPRN-jRCTs062180048
JPRN-jRCTs062180048RecruitingPhase 1

Effects and safety of narrowband UVB irradiation on gene expression of histamine H1 receptor and allergy-related cytokine in nasal mucosa of healthy subjects: a phase 1 study - A phase 1 study of narrow-band UVB

Kitamura Yoshiaki0 sites20 target enrollmentStarted: March 14, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to < 65age old (—)
Sex
All

Inclusion Criteria

  • 1) Adult subjects aged 20 or above
  • 2) Healthy subjects without allergic rhinitis and taking any anti-allergic medications

Exclusion Criteria

  • 1) Subjects with serious complications
  • 2) Subjects who was excluded by investigators

Investigators

Sponsor
Kitamura Yoshiaki

Similar Trials